IDDF2020-ABS-0038 Analysis and identification of disruptive gut microbiota and its perturbed metabol...
IDDF2020-ABS-0038 Analysis and identification of disruptive gut microbiota and its perturbed metabolic functions and recognition of potential novel therapeutic targets in decompensated cirrhosis with sepsis
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundThe role of intestinal-dysbiosis leading to adverse outcomes is well known in sepsis and septic shock. Variations in bacterial diversity and microbiota-related functional-metabolic alterations within the gut microbiome in decompensated cirrhosis (DC) patients with sepsis remain unknown.Methods16-srRNA sequencing on stool samples (n=51,sep...
Alternative Titles
Full title
IDDF2020-ABS-0038 Analysis and identification of disruptive gut microbiota and its perturbed metabolic functions and recognition of potential novel therapeutic targets in decompensated cirrhosis with sepsis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2461835569
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2461835569
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2020-IDDF.12
